These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 21954634)
1. [Relationship of silent myocardial ischiemia with the course of rheumatoid arthritis and hyperhomocysteinemia]. Galiutina OIu; Bychak OV Lik Sprava; 2011; (1-2):48-52. PubMed ID: 21954634 [TBL] [Abstract][Full Text] [Related]
2. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Lopez-Olivo MA; Gonzalez-Lopez L; Garcia-Gonzalez A; Villa-Manzano AI; Cota-Sanchez AR; Salazar-Paramo M; Varon-Villalpando E; Cardona-Muñoz EG; Gamez-Nava JI Scand J Rheumatol; 2006; 35(2):112-6. PubMed ID: 16641044 [TBL] [Abstract][Full Text] [Related]
3. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis. Woolf K; Manore MM J Am Diet Assoc; 2008 Mar; 108(3):443-53; discussion 454. PubMed ID: 18313425 [TBL] [Abstract][Full Text] [Related]
4. Severe atherosclerosis in rheumatoid arthritis and hyperhomocysteinemia: is there a link? El Bouchti I; Sordet C; Kuntz JL; Sibilia J Joint Bone Spine; 2008 Jul; 75(4):499-501. PubMed ID: 18457979 [TBL] [Abstract][Full Text] [Related]
5. Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease. Wisłowska M; Sypuła S; Kowalik I Clin Rheumatol; 1998; 17(5):369-77. PubMed ID: 9805180 [TBL] [Abstract][Full Text] [Related]
6. Moderate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis. Schroecksnadel K; Frick B; Kaser S; Wirleitner B; Ledochowski M; Mur E; Herold M; Fuchs D Clin Chim Acta; 2003 Dec; 338(1-2):157-64. PubMed ID: 14637281 [TBL] [Abstract][Full Text] [Related]
7. [Painless myocardial ischemia in patients with rheumatoid arthritis]. Striuk RI; Leonova EA; Tedikova NS; Gosteva OV Ter Arkh; 2008; 80(5):16-20. PubMed ID: 18590108 [TBL] [Abstract][Full Text] [Related]
8. [Hyperhomocysteinemia--a predictor of inflammatory changes in the liver]. Zviagintseva TD; Hlushchenko SV Lik Sprava; 2014 Nov; (11):154-5. PubMed ID: 25528857 [TBL] [Abstract][Full Text] [Related]
9. The impact of hyperhomocysteinemia as a cardiovascular risk factor in the prediction of coronary heart disease. Geisel J; Hennen B; Hübner U; Knapp JP; Herrmann W Clin Chem Lab Med; 2003 Nov; 41(11):1513-7. PubMed ID: 14656034 [TBL] [Abstract][Full Text] [Related]
10. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Brown DA; Moore J; Johnen H; Smeets TJ; Bauskin AR; Kuffner T; Weedon H; Milliken ST; Tak PP; Smith MD; Breit SN Arthritis Rheum; 2007 Mar; 56(3):753-64. PubMed ID: 17328047 [TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation. Jensen OK; Rasmussen C; Mollerup F; Christensen PB; Hansen H; Ekelund S; Thulstrup AM J Rheumatol; 2002 Aug; 29(8):1615-8. PubMed ID: 12180718 [TBL] [Abstract][Full Text] [Related]
12. Effects of Alpha-Lipoic Acid Supplementation on Inflammatory Biomarkers and Matrix Metalloproteinase-3 in Rheumatoid Arthritis Patients. Mirtaheri E; Gargari BP; Kolahi S; Dehghan P; Asghari-Jafarabadi M; Hajalilou M; Shakiba Novin Z; Mesgari Abbasi M J Am Coll Nutr; 2015; 34(4):310-7. PubMed ID: 25751300 [TBL] [Abstract][Full Text] [Related]
13. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547 [TBL] [Abstract][Full Text] [Related]
15. Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: a predictive marker. Tarkun I; Cetinarslan B; Cantürk Z; Tarkun P; Agaçdiken A; Komsuoglu B J Diabetes Complications; 2004; 18(3):165-8. PubMed ID: 15145328 [TBL] [Abstract][Full Text] [Related]
16. IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis. Troelsen LN; Jacobsen S; Abrahams JL; Royle L; Rudd PM; Narvestad E; Heegaard NH; Garred P J Rheumatol; 2012 Mar; 39(3):463-9. PubMed ID: 22247351 [TBL] [Abstract][Full Text] [Related]
17. The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors? López-Longo FJ; Sánchez-Ramón S; Carreño L Drug News Perspect; 2009 Nov; 22(9):543-8. PubMed ID: 20072731 [TBL] [Abstract][Full Text] [Related]
18. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults. Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644 [TBL] [Abstract][Full Text] [Related]
19. Inflammation and hypertension in rheumatoid arthritis. Manavathongchai S; Bian A; Rho YH; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM J Rheumatol; 2013 Nov; 40(11):1806-11. PubMed ID: 23996293 [TBL] [Abstract][Full Text] [Related]
20. Plasma homocysteine level and uveitis in Behçet's disease. Okka M; Oztürk M; Kockar MC; Bavbek N; Rasier Y; Gunduz K Isr Med Assoc J; 2002 Nov; 4(11 Suppl):931-4. PubMed ID: 12455183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]